Diabetes Care· 2017Q1
International Consensus on Use of Continuous Glucose Monitoring
- 2,033citations
- Q1SCImago
- 2017year
Short summary
An international panel established consensus recommendations for using continuous glucose monitoring (CGM) to improve diabetes management beyond HbA1c.
AI-generated from the title and abstract; the full text is not read.
Key points
- HbA1c does not capture glycemic excursions, which are linked to diabetes complications.
- Continuous Glucose Monitoring (CGM) offers a more complete picture of glycemic control than HbA1c or self-monitoring of blood glucose.
- Standardized metrics for analyzing CGM data and criteria for matching patients to monitoring methods were lacking.
- An international expert panel established consensus recommendations to guide CGM use and interpretation.
AI-generated from the title and abstract; the full text is not read.
Abstract
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
The authors' abstract, as published at the source. Diabetes Care, 2017 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and MetabolismMedicine